MedPath

Safety of Sticker Pad Containing Essential Oil Containing Lavender and Ylang-ylang Oil

Not Applicable
Completed
Conditions
Healthy
Registration Number
NCT05791266
Lead Sponsor
Chulalongkorn University
Brief Summary

The aims of the study were to evaluate safety of sticker pads containing lavender and ylang ylang oil in healthy volunteers.

Detailed Description

The lavender and ylang ylang oil pad was attached to the shirts of healthy volunteers for 2 hours. The outcomes were evaluated before, during and 30 minutes after removal of the pad. Adverse reactions, irritation score, and quality of life were assessed. Blood pressure and pulse rate were also measured

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  • age 18 to 60 years
  • no allergic history of lavender and ylang ylang oil
  • no dermatological diseases, immunocompromised diseases, seizures, asthma, or respiratory diseases.
Exclusion Criteria
  • an unstable condition of other diseases
  • olfactory problems
  • pregnancy
  • lactation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Adverse reactions of the respiratory tract, skin, eye, and central nervous system2 hours

The severity scores were 0 (no symptoms) to 3 (severe symptoms)

Secondary Outcome Measures
NameTimeMethod
Irritation of eye, respiratory, other neurological, and toxicity reaction2 hours

Using a 0 to 100 scale, following an increase of severity

Pulse rate2 hours

Measure pulse rate in beats/minutes

Rhinoconjunctivitis quality of life questionnaire2 hours

Using a score of 1 (no problems) to 5 (severe problem)

Diastolic blood pressure2 hours

Measure diastolic blood pressure in mmHg

Systolic blood pressure2 hours

Measure systemic blood pressure in mmHg

Trial Locations

Locations (1)

Chulalongkorn Hospital

🇹🇭

Bangkok, Thailand

Chulalongkorn Hospital
🇹🇭Bangkok, Thailand

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.